FILTER

FILTERED INTERVIEW RESULTS

Giovanni Mariani

CEO, LISAPHARMA
Lisapharma describes the challenges Italian pharma producers have experienced over the past two years.

Rocco Pavese

CEO, GENETIC SPA
Genetic is an Italian CDMO founded in 2007 dedicated to the research and development, manufacturing, licensing-out and marketing of medicines.

Alessia Valducci

CEO, VALPHARMA
Valpharma is an Italian CMO involved in pharmaceutical development and contract manufacturing specializing in solid oral dosage medicines and nutraceuticals, both developed with modified-release technologies.

Pasquale de Blasio

FOUNDER, INTEGRATED SYSTEMS ENGINEERING (ISE)
Integrated Systems Engineering sets out its objectives to develop its TMA technology and move it into diagnostics and to build a biobank of organoids.

Massimo Versace

COUNTRY MANAGER, SUN PHARMA ITALY
Sun Pharma discusses its’ operations in Italy.

Giorgio Palu

PRESIDENT, AIFA
The Italian Medical Agency (AIFA) explains the current issues facing Italy’s life science industry.

Pierfrancesco Morosini

CEO, ICROM
Icrom is an Italian CDMO leader for the production of APIs and GMP intermediates.

Federico Chinni

MANAGING DIRECTOR, UCB ITALY
UCB Italy explains the specifications of the Italian health and pharma sector.

Fabrizio Chines

CHAIRMAN & CEO, SIFI GROUP
SIFI Group explains its pipeline and its plans for expansion in the ophthalmology space.

Maurizio Sartorato

CEO BIDACHEM SPA
Bidechem SPA explains its strategy for sustainable business growth.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Ontario Mining and Toronto's Global Reach 2024 - Digital Interactive

GBR’s annual Ontario Mining and Toronto’s Global Reach 2024 report draws from over 100 interviews with leading executives from major producers, associations, juniors, consultants, investors, and service providers, to provide an in-depth and holistic view of what is happening now, and more pertinently, what could happen in the years ahead.

PARTNER EVENTS